Status:
COMPLETED
Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
Lead Sponsor:
Unidad de Cirugia Bariatrica Hospital Civil Dr. Juan I. Menchaca
Conditions:
Weight Loss
Bariatric Surgery Candidate
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Severe obesity is associated with considerable reduction of wellbeing and life expectancy. People living with severe obesity tend to die 8 to 10 years earlier. Preoperative management of patients livi...
Detailed Description
Objective: Determine liraglutide effectiveness for preoperative weight-loss in patients with severe obesity undergoing bariatric-metabolic surgery. Methods: It is a single center, quasi-experimenta...
Eligibility Criteria
Inclusion
- Patients with BMI greater than 48 kg/m2 in pre-surgical protocol for bariatric surgery of the Bariatric and Metabolic Surgery Unit of the Civil Hospital of Guadalajara "Dr. Juan I. Menchaca
Exclusion
- Patients under 18 years of age or over 65 years of age.
- Pregnant patients.
- Patients who do not agree to give their consent and take part in the study.
- Patients with allergy to liraglutide, multiple endocrine neoplasia type 2 and medullary thyroid cancer, gallstones.
- Removal:
- Patients who decide to abandon the study.
- Patients who do not follow the instructions or do not adhere to the treatment.
Key Trial Info
Start Date :
December 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT06201819
Start Date
December 18 2022
End Date
May 1 2023
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departamento de Cirugia Bariatrica y Metabolica del Hsopital Civil Dr. Juan I. Menchaca
Guadalajara, Jalisco, Mexico, 44340